98%
921
2 minutes
20
Introduction: Describe factors associated with parametrial involvement, and how these factors modify the prognosis of patients with endometrial carcinoma treated with radical hysterectomy.
Methods: Observational study in which categorized patients according to those with and without parametrial involvement. A descriptive analysis and comparative analysis were performed for associations between parametrial spread and clinical, surgical, and pathology variables.
Results: We analyzed 85 patients, which 18 (21%) had parametrial involvement. Pathology factors associated with parametrial involvement were the endometrioid subtype, grade 3, and variants of poor prognosis (odds ratio (OR) 3.41, 95% CI 1.09-10.64; = 0.035), myometrial invasion of over 50% (OR 7.76, 95% CI 1.65-36.44; = 0.009), serosal involvement (OR 17.07, 95% CI 3.87-75.35; < 0.001), ovarian metastasis (OR 5.15, 95% CI 1.36-19.46; = 0.016), positive peritoneal cytology (OR 3.9, 95% CI 1.04-14.77; = 0.044), and lymph node metastasis (OR 3.4; 95% CI 1.16-9.97; = 0.026). Five-year disease-free survival was 74% (95% CI 57.4-85.4) for the group without parametrial spread and 50.8% (95% CI 22.7-73.4) for the group with parametrial spread ( = 0.001). Similarly, 5-year overall survival was 85.2% (95% CI 67.9-93.6) for the group without parametrial spread and 47.5% (95% CI 8.1-80.2) for the group with parametrial spread ( = 0.002).
Conclusion: Factors associated with parametrial involvement were histologies of poor prognosis, tumors affecting uterine serosa, cervix, or spread beyond the uterus. Additionally, parametrial involvement directly affects prognosis by reducing overall survival, disease-free survival and increasing odds for recurrence.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1177/10668969231225773 | DOI Listing |
Ultrasound Obstet Gynecol
August 2025
Centro Integrato di Procreazione Medicalmente Assistita (PMA) e Diagnostica Ostetrico-Ginecologica, Policlinico Universitario Duilio Casula, University of Cagliari, Cagliari, Italy.
Objective: To perform an updated meta-analysis evaluating the diagnostic performance of transvaginal ultrasound (TVS) for detecting lateral parametrial involvement in women with suspected deep pelvic endometriosis.
Methods: A literature search was performed in the Web of Science, PubMed and Scopus databases from January 2021 to May 2024 for studies evaluating TVS for detecting parametrial involvement in women with suspected deep pelvic endometriosis, using laparoscopy with or without histology as the reference standard. The information gathered was combined with data from our previous meta-analysis on this topic.
Int J Gynaecol Obstet
August 2025
Department of Obstetrics and Gynecology and CERICSAL (CEntro di RIcerca Clinico SALentino), Veris Delli Ponti Hospital, Scorrano, Italy.
Objective: Abnormal placenta accreta spectrum (PAS), particularly placenta percreta 3b and 3c (FIGO 2019), involving bladder wall or parametrial tissue attachment, presents significant surgical risks including massive bleeding and organ injury. Multidisciplinary management and innovative surgical approaches are essential. The aim of the present study was to evaluate endovascular balloon occlusion of the abdominal aorta (EBOAA) versus internal iliac artery ligation (IIAL) techniques in managing placenta percreta 3b and 3c and preventing massive bleeding and other complications, by a retrospective cohort case-control study.
View Article and Find Full Text PDFTher Adv Med Oncol
July 2025
Department of Gynecological Radiotherapy, Zhejiang Cancer Hospital, 1 Banshan East Road, Hangzhou 310022, Zhejiang, China.
Background: Gastric-type endocervical adenocarcinoma (GAS), the predominant non-human papillomavirus cervical cancer, is highly aggressive with poor prognosis. No drugs are effective against advanced or recurrent GAS.
Objective: This study aimed to analyze the clinical and pathological characteristics of GAS, evaluate the expression of targets for targeted drug therapy, and assess the predictive value of Immunoscore for prognosis.
Asian Pac J Cancer Prev
July 2025
Department of Gynecologic Oncology, Akdeniz University, Faculty of Medicine, Antalya, Turkiye.
Aim: Cervical cancer is the fourth most common malignancy in women worldwide and the second leading cause of cancer related mortality globally, making it a significant public health problem. Half of the women diagnosed are at an early stage; these women are typically young, mainly nulliparous, and have a long life expectancy. Less radical surgery is an attractive option for this selected group.
View Article and Find Full Text PDFJ Gynecol Oncol
July 2025
Department of Radiation Oncology, Chung-Ang University College of Medicine, Seoul, Korea.
Background: For patients with high-risk factors such as pelvic lymph node metastasis, positive surgical margins, or parametrial involvement, concurrent chemoradiotherapy (CCRT) with whole-pelvic radiotherapy significantly improves survival outcomes. Hypofractionated radiation therapy, which delivers higher radiation doses over fewer sessions, enhances tumor control but raises concerns about increased normal tissue toxicity. A recent Korean phase II study (POHIM-CCRT) evaluated the safety of hypofractionated intensity-modulated radiation therapy (IMRT), delivering 40 Gy in 16 fractions with weekly cisplatin following radical surgery.
View Article and Find Full Text PDF